Latest News

Print

Another report on possible Alzheimer’s breakthrough.

Dr. Dale Bredesen, Augustus Rose Professor of Neurology and Director of the Mary S. Easton Center for Alzheimer's Disease Research, was featured Oct. 7 by Esquire.com regarding his research showing that memory loss in patients with Alzheimer’s may be reversed, and improvement sustained, using a complex, 36-point therapeutic program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry.

The study:
Bredesen, DE. Reversal of cognitive decline: A novel therapeutic program. AGING 2014;6(9):1-11.

Print

Media continues coverage on possible breakthrough in treating Alzheimer’s.

Dr. Dale Bredesen, Augustus Rose Professor of Neurology and Director of the Mary S. Easton Center for Alzheimer's Disease Research, continued to be featured by the media regarding his research showing that memory loss in patients with Alzheimer’s may be reversed, and improvement sustained, using a complex, 36-point therapeutic program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry. Coverage included Sept. 30 on KCPQ-Channel 13 (Seattle, Wash.); two spots Oct. 3 on KABC-Channel 7 ( AM & PM), and in Examiner.com; Oct. 6 in WebMD; Oct. 7 on KTRK-Channel 13 (Houston, Texas), KARE-Channel 11 (Tampa Bay, Fla.), DailyDigestNews.com and SeniorJournal.com; and Oct. 8 on KCCI-Channel 9 (Des Moines, Iowa).

The study:
Bredesen, DE. Reversal of cognitive decline: A novel therapeutic program. AGING 2014;6(9):1-11.

Print

A ground-breaking treatment at UCLA improves failing memories of some patients.

Dr. Dale Bredesen, Augustus Rose Professor of Neurology and Director of the Mary S. Easton Center for Alzheimer's Disease Research, was featured by the media regarding his research showing that memory loss in patients with Alzheimer’s may be reversed, and improvement sustained, using a complex, 36-point therapeutic program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry. Coverage included Sept. 29 reports by KTLA-Channel 5, KNBC-Channel 4, and Consumeraffairs.com; and Oct. 1 stories in the San Jose Mercury News, Medical News Today, AskMen.com, NewsMaxHealth.com, Techtimes.com, Empowher.com, Bioscience Technology, Contra Costa Times, and the Marin Independent Journal.

The study:
Bredesen, DE. Reversal of cognitive decline: A novel therapeutic program. AGING 2014;6(9):1-11.

Print

Los Angeles Times highlights frontal temporal dementia in documentary.

Dr. Mario Mendez, Professor of Psychiatry and Neurology and Director of the Behavioral Neurology Program, and Jill Shapira, Nurse Practitioner (retired), were featured in a Los Angeles Times and Direct TV video story called “Losing Stu.” The video profiled his patient who suffered from frontal temporal dementia, and was based on a Feb. 12, 2012 Los Angeles Times article.

Print

WebMD explores latest advances in fighting Alzheimer’s.

Dr. Dale Bredesen, Augustus Rose Professor of Neurology and Director of the Mary S. Easton Center for Alzheimer's Disease Research, was featured in an Aug. 20 WebMD Q&A about the latest treatment and prevention strategies for Alzheimer's disease.